Trotabresib

DB17421InvestigationalSmall molecule

Trotabresib is an oral, potent, and reversible inhibitor of the epigenetic target bromodomain and extra-terminal (BET) proteins.

Mechanism
Curator reviewed
Also known as
1(2h)-isoquinolinone, 4-(2-(cyclopropylmethoxy)-5-(methylsulfonyl)phenyl)-2-methyl- · 4-(2-(cyclopropylmethoxy)-5-methylsulfonylphenyl)-2-methylisoquinolin-1-one · Bet inhibitor cc-90010
Code names
BMS-986378 · CC-90010

Resolves to

What you can answer from here — as of November 03, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
8+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Trotabresib, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account